510(k) K820835
K820835 is an FDA 510(k) premarket notification submitted by Hyland Therapeutic Div., Travenol Laboratories for the device "ALUMINA SILICA-ACTIVATED PARTIAL THROM". The FDA issued a decision of Substantially Equivalent on April 26, 1982. The device falls under product code GFO (Activated Partial Thromboplastin), a Class II device regulated under 21 CFR 864.7925. Hyland Therapeutic Div., Travenol Laboratories has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- April 26, 1982
- Date Received
- March 26, 1982
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Activated Partial Thromboplastin
- Device Class
- Class II
- Regulation Number
- 864.7925
- Review Panel
- HE
- Submission Type